Evidence map›Paper›PMID 40060323›Full record

ArticleEnvironmental and occupational health practice2022

Prediction and predictor elucidation of metabolic syndrome onset among young workers using machine learning techniques: A nationwide study in Japan.

Miyuki Suda, Tadao Ooka, Zentaro Yamagata

Abstract read
In one paragraph

Article in Environmental and occupational health practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miyuki SudaDepartment of Health Science, University of Yamanashi, Chuo, Yamanashi, Japan.
Tadao OokaDepartment of Health Science, University of Yamanashi, Chuo, Yamanashi, Japan.ORCID https://orcid.org/0000-0002-1343-3986
Zentaro YamagataDepartment of Health Science, University of Yamanashi, Chuo, Yamanashi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Predictive models for the onset of metabolic syndrome (MS) for people in their 30s are scarce. This study aimed to construct a highly accurate model to predict MS onset by 40 years of age and to identify important predictors of MS onset using health checkup data of Japanese employees aged between 30 and 35 years. Methods: The study included 6,048 Japanese employees aged 40 years who underwent periodic health examinations over 10 years. We developed predictive models for MS onset using machine learning methods, including random forest and logistic regression models. The variable importance of each explanatory variable was calculated to identify important predictors of MS onset for the random forest models. Results: Of 2,998 participants, 164 participants aged 30 and 180 of 4,045 participants aged 35 years developed MS by age 40 years. The random forest models have the highest predictive power (e.g., AU-ROC 0.867 for males aged 30) compared to the logistic regression models. In these models, diastolic blood pressure was the most important predictor of MS onset for males, while body mass index was the most important predictor for females. Conclusions: We created machine learning models to predict MS onset at the age of 40 years with high accuracy from health examination data obtained at the age of 30 or 35 years. Sex differences in important predictors of MS onset were shown by the variable importance indices of the random forest. Applying our model in routine healthcare management could provide early health interventions to prevent MS onset.

Indexed as

blood pressurebody mass indexmachine learningmetabolic syndromeobesityrisk

Identifiers

PMID40060323
PMCPMC11841789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.